Shockwave breakthrough opens door for heart valve fix in Hard-to-Treat patients
NCT ID NCT05862558
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a special shockwave balloon (intravascular lithotripsy) to safely widen heavily calcified arteries in the pelvis, allowing a less invasive heart valve replacement (TAVR) in patients who otherwise would need a more risky approach. About 50 adults with severe aortic stenosis and blocked iliac arteries will receive the shockwave treatment before TAVR. The goal is to see if this technique makes the procedure safer and more successful.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor Scott and White Heart Hospital
RECRUITINGPlano, Texas, 75093, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single stitch beat a double closure for TAVI patients?
- Can a fitness app boost recovery after heart valve replacement?
- A new heart valve without Open-Heart surgery: can it help High-Risk patients?
- Can a single antiplatelet drug beat aspirin after heart valve replacement?
- Can common heart-surgery practices trigger delirium? a 5,600-patient hunt for clues.
- Which heart valve works best for small aortic openings? a Head-to-Head trial